Amador Bioscience

Amador Bioscience is a next-generation provider of translational research and clinical development solutions. As a global contract research organization (CRO) with established sites in the United States, Europe, and China, Amador confidently meets international clinical trial quality and compliance standards.  

We enhance the success rate of new drugs in any regulatory setting by scientifically calculating the right dose, for the right target, in the right patient. Let us help you take your innovative drug discovery projects from pre-clinical research and development to market approval.